OneDigital Investment Advisors LLC increased its position in shares of Manhattan Associates, Inc. (NASDAQ:MANH – Free Report) by 3.8% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 6,267 shares of the software maker’s stock after purchasing an additional 228 shares during the quarter. OneDigital Investment Advisors LLC’s holdings in Manhattan Associates were worth $1,763,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently bought and sold shares of the company. Innealta Capital LLC purchased a new stake in shares of Manhattan Associates in the 2nd quarter worth about $26,000. International Assets Investment Management LLC purchased a new stake in shares of Manhattan Associates in the second quarter valued at about $27,000. Capital Performance Advisors LLP purchased a new position in shares of Manhattan Associates during the 3rd quarter worth approximately $34,000. Ashton Thomas Private Wealth LLC purchased a new position in shares of Manhattan Associates during the 2nd quarter worth approximately $31,000. Finally, DT Investment Partners LLC acquired a new position in shares of Manhattan Associates during the 2nd quarter worth approximately $31,000. 98.45% of the stock is currently owned by hedge funds and other institutional investors.
Manhattan Associates Trading Down 2.5 %
MANH stock opened at $272.62 on Monday. The company has a market cap of $16.65 billion, a PE ratio of 77.45 and a beta of 1.52. The stock has a 50-day moving average price of $279.80 and a two-hundred day moving average price of $252.76. Manhattan Associates, Inc. has a 12-month low of $199.23 and a 12-month high of $307.50.
Wall Street Analyst Weigh In
A number of research firms have issued reports on MANH. DA Davidson upped their target price on shares of Manhattan Associates from $285.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. StockNews.com downgraded shares of Manhattan Associates from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Raymond James boosted their price target on Manhattan Associates from $255.00 to $305.00 and gave the company an “outperform” rating in a report on Wednesday, October 23rd. Citigroup raised their price objective on Manhattan Associates from $257.00 to $287.00 and gave the stock a “neutral” rating in a report on Wednesday, September 25th. Finally, Truist Financial upped their target price on Manhattan Associates from $275.00 to $310.00 and gave the company a “buy” rating in a research note on Friday, October 11th. Four investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $286.38.
View Our Latest Stock Report on Manhattan Associates
About Manhattan Associates
Manhattan Associates, Inc develops, sells, deploys, services, and maintains software solutions to manage supply chains, inventory, and omni-channel operations. It offers Warehouse Management Solution for managing goods and information across the distribution centers; Manhattan Active Warehouse Management, a cloud native and version less application for the associate; and Transportation Management Solution for helping shippers navigate their way through the demands and meet customer service expectations at the lowest possible freight costs; Manhattan SCALE, a portfolio of logistics execution solution; and Manhattan Active Omni, which offers order management, store inventory and fulfillment, POS, and customer engagement tools for enterprises and stores.
Further Reading
- Five stocks we like better than Manhattan Associates
- Find and Profitably Trade Stocks at 52-Week Lows
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- The 3 Best Fintech Stocks to Buy Now
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Manhattan Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Manhattan Associates and related companies with MarketBeat.com's FREE daily email newsletter.